The acquisition will enhance NTT DATA's offerings by integrating ProvenTech's innovative products and services, which include SaaS solutions, automation, integration, and advisory services tailored to the pharmaceutical industry's needs. ProvenTech's expertise in SAP© S/4HANA and other enterprise software will complement NTT DATA's global presence and expand their market reach and innovation in the Life Sciences sector.
Post acquisition, ProvenTech will become a subsidiary of NTT DATA Business Solutions Private Limited in India and will operate as an independent company after the acquisition, using the brand name "ProvenTech, an NTT DATA Company".
This move is in line with NTT DATA's strategy to expand in the Pharma/Life Science focus industry and is expected to optimize the cross-selling of SAP ERP with enhanced pharmaceutical solutions in India and the APAC region. The acquisition is seen as a significant step towards transforming shopfloor processes with advanced technologies and improving operational efficiency and compliance in the pharmaceutical industry.
Founded in 2020, by Ravi Sangisetti and P. Raju Venkata, ProvenTech Pvt Ltd is focused on providing cutting-edge GenAI-driven Quality Management and Manufacturing solutions to the Pharma, Healthcare, and Food industry. The company's leadership and vision have been instrumental in ProvenTech's growth and success, culminating in the acquisition by NTT DATA Business Solutions AG.
The acquisition of ProvenTech by NTT DATA is expected to have a positive impact on ProvenTech's existing clients. ProvenTech's clients will likely benefit from the integration of advanced GenAl-driven Quality Management and Manufacturing solutions, which can improve operational efficiency and compliance in the Pharma, Healthcare, and Food industries
With NTT DATA's global presence, Proven Tech's clients may gain access to a broader range of services and support, potentially opening up new opportunities for innovation and growth.
Advertisements